Renaissance Technologies
MENS

Renaissance Technologies’s Jyong Biotech MENS Stock Holding History

Renaissance Technologies’s Portfolio MENS Stock Details MENS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47.4K Buy
+22,900
New +$48.6K ﹤0.01% 3052

Other funds holding MENS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
SOW
State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Renaissance Technologies's MENS Position: Q2 2026 in Review

Renaissance Technologies opened a new position in Jyong Biotech (MENS) in Q2 2026: 22,900 shares worth $47.4K. The stake represents ﹤0.01% of the portfolio and ranks #3052 among its holdings.

19 funds tracked by Wall St. Rank hold MENS as of Q2 2026.

  • Renaissance Technologies held 22,900 shares of Jyong Biotech worth $47.4K as of Q2 2026.
  • Jyong Biotech was a new Renaissance Technologies position in Q2 2026.
  • Jyong Biotech made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #3052 holding.
  • 19 funds tracked by Wall St. Rank held Jyong Biotech as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.